TAKE A LOOK AT WHICH REPORT YOUR PORTFOLIO'S BEEN MISSING...

Shareholders Foundation offers real-time reporting of class action exposure on a per transaction basis,
including the documents you will need for claim filing and settlement recovery.
Start Monitoring Your Investments
  • Shareholders Foundation monitors Class Action Investigations, Cases, and Class Action Settlements.
    Learn More >>>
  • Create Notifications and monitor one Case or multiple Cases. Or submit your entire portfolio! Learn More >>>

Dynavax Technologies Corporation (NASDAQ:DVAX) Investor Investigation Over Potential Securities Laws Violations

  • If you purchased shares of Dynavax Technologies Corporation (NASDAQ:DVAX), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

June 17, 2013 (Update) - On June 10, 2013 - Dynavax Technologies Corporation reported that it recently concluded a meeting with the U.S. Food and Drug Administration (FDA) regarding its Biologic License Application for HEPLISAV, an investigational adult hepatitis B vaccine. Shares of Dynavax Technologies Corporation (NASDAQ:DVAX) fell from $2.55 per share on June 6, 2013 to $1.22 per ...



You must register (for free) or login to view the entire investigation.

Click here to Sign In or Register (for a free account)